EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES - FINAL PROGRAM - Mediterranean Rheuma
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC
AND MUSCULOSKELETAL DISEASES
This course is a
EULAR Endorsed Course
FINAL PROGRAM
PATRONAGES
European League Against
the Rheumatism (EULAR)
Italian Society of Rheumatology
(Società Italiana di Reumatologia – SIR)
ERN ReCONNETT
The University of Genoa
The Department of internal medicine
and medical specialities (DiMI),
University of Genoa
The Region Liguria
The IRCCS Polyclinic Hospital
San Martino Genoa
The Metropolitan City of Genoa
www.mediterraneanrheuma.com
The City of GenoaEFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
INDEX WELCOME
Welcome 5
From at least 2,000 years the Mediterranean area with the connected
Congress Chairperson 5 Black and Red Sea populations has been the “CRIB” of the culture,
and Scientific Board
science and good life.
Advisors 6-7
Program Overview 8-10 What does good life mean?
Good life means an acceptable style of life, This 2018 edition of the Congress will focus
Scientific Program 11-29 even modest but healthy, and of course, it on the effects of diet and climate on the most
Thursday 12th April, 2018 includes good food and good climate! Today, we frequent Rheumatic and Musculoskeletal
Friday 13th April, 2018 recognize that, among the multiple risk factors Diseases, including their early diagnosis and
Saturday 14th April, 2018 involved in the development of several diseases, advanced therapies. The Congress topics will
environmental and nutritional components be discussed in sequential sessions and will
Poster Tours 30-50 play an important role. The rheumatic diseases include appropriate presentations on nutritional
are among the most common diseases in the and environmental factors that will integrate the
Scientific Information 51-53 general population and the effects of incorrect clinical and drug treatment lectures.
Abstract book diets and non-healthy environment/style of
Guidelines for chairpersons and speakers Of course, the participants will have the
Oral Communications and Poster tours
life, are recognized as important promoters occasion to taste personally in spring time,
UEMS and ITALIAN CME Accreditation for their development. A correct diet also the therapeutical effects of the Mediterranean
represents part of a correct management of diet and climate “available” for all participants
General Information 54-63 the Rheumatic & Musculoskeletal Diseases. during the Congress that will be held in the Old
Congress Venue Already from the beginning, the Mediterranean Harbour of Genoa.
How to reach the Venue Congress of Rheumatology has presented the
Congress Centre Parking experiences regarding the characteristics
Floorplan of the Rheumatic Diseases in such an area,
Exhibitors and compared their epidemiology among the
Organizing Secretariat
European countries.
Opening Hours
Registration Information
Networking Evening
Social Media
CONGRESS CHAIRPERSON
Useful Information 64-65 M. Cutolo Genoa, Italy
Admission
On the behalf of the Board of the Mediterranean Congress of Rheumatology
Language
and of Italian Society of Rheumatology
Attendance Certificates
Wi-Fi
Coffee break and Lunch XVII MEDITERRANEAN CONGRESS SCIENTIFIC BOARD
Cloakroom
Insurance
N. Akkoc Izmir, Turkey M. Inanc Istanbul , Turkey
No-Smoking
Privacy Disclosure and Publishing of Images
L. Carmona Madrid, Spain G.D. Kitas Manchester, UK
Taxi Discount reserved to attendees B. Combe Montpellier, France M. Kouloumas Nicosia, Cyprus
N. Damjanov Belgrade, Serbia P. Sfikakis Athens, Greece
Concomitants Industry-Sponsored L. Denisov Moscow, Russia Y. Shoenfeld Tel Aviv, Israel
SATELLITE LECTURES and SYMPOSIA 66-67 J.E. Fonseca Lisbon, Portugal S.G. Sokolovic Sarajevo, Bosnia and Herzegovina
M. Gattorno Genoa, Italy S.G. Sukkar Genoa, Italy
Patients Associations S. Grazio Zagreb, Croatia Z. Szekanecz Debrecen, Hungary
A. Iagnocco Turin, Italy A. Tzioufas Athens, Greece
Acknowledgements
4 5MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
ADVISORS
INTERNATIONAL ADVISORS NATIONAL ADVISORS LOCAL ADVISORS
N. Akkoc Izmir, Turkey M. Kouloumas Nicosia, Cyprus S. Antonelli Rome, Italy P. Comanducci
S. Aligrutic Podgorica, Montenegro E.J. Kucharz Katowice, Poland G. Arioli Mantua, Italy Rector University of Genoa
A. Alunno Perugia, Italy A. Ladjouze Algiers, Algeria G. Bajocchi Reggio Emilia, Italy
B. Anic Zagreb, Croatia C. Mallia Msida, Malta M. Bentivegna Ragusa, Italy M. Amore
S. Ataman Ankara, Turkey X. Mariette Paris, France R. Caporali Pavia, Italy Dean School of Medicine University of Genoa
M. Reda Awad Agouza, Giza, Egypt A. Martini Genoa, Italy S. D’Angelo Potenza, Italy
H. Bassiouni Cairo, Egypt M. Matucci Cerinic Florence, Italy L. Di Matteo Pescara, Italy G. Ucci
S. Bombardieri Pisa, Italy I. McInnes Glasgow, UK M. Galeazzi Siena, Italy CEO of the Polyclinic Hospital San Martino
J.W.J. Bijlsma Utrecht, The Netherlands G. Minisola Rome, Italy R. Gerli Perugia, Italy
D. Boumpas Athens, Greece P. Miossec Lyon, France A. Mathieu Cagliari, Italy G. La Valle
G.R. Burmester Berlin, Germany S. Mishevska-Percinkova Skopje, Republic of Macedonia I. Olivieri† Potenza, Italy Chief Medical Officer of the Polyclinic Hospital
L. Carmona Madrid, Spain C. Montecucco Pavia, Italy L. Quartuccio Udine, Italy San Martino
C. Christodoulou Larnaca, Cyprus M. Mosca Pisa, Italy F. Salaffi Ancona, Italy
B. Coleiro Birkirkara, Malta E. Nasonov Moscow, Russia G. Sebastiani Rome, Italy S. Viale
B. Combe Montpellier, France E. Nikiphorou London, UK L. Sinigaglia Milan, Italy CEO Health System & Vice President
J.A.P. Da Silva Coimbra, Portugal C.H. Opava Huddinge, Sweden A. Tincani Brescia, Italy of Liguria Government
N. Damjanov Belgrade, Serbia N. Prodanovic Banja Luka, Republic of Srpska - Bosnia Herzegovina G. Valesini Rome, Italy
L. Denisov Moscow, Russia R. Rashkov Sofia, Bulgaria M. Bucci
A. Dinc Çankaya, Turkey A. Ravelli Genoa, Italy Major of the City of Genoa
H. Direskeneli Istanbul, Turkey P. Sarzi Puttini Milan, Italy
A. Doria Padua, Italy J. Sellam Paris, France S. Balleari
A. El Garf Cairo, Egypt P. Sfikakis Athens, Greece Vice Major of the City of Genoa
O. Elkayam Tel Aviv, Israel Y. Shoenfeld Tel Aviv, Israel
K. Elmuntaser Tripoli, Libya V. Smith Ghent, Belgium
J.E. Fonseca Lisbon, Portugal S. Sokolovic Sarajevo, Bosnia and Herzegovina
M. Gattorno Genoa, Italy R. Straub Regensburg, Germany
S. Grazio Zagreb, Croatia S.G. Sukkar Genoa, Italy
A. Gul Istanbul, Turkey Z. Szekanecz Debrecen, Hungary MEDICAL TEAM
N. Hajjaj-Hassouni Rabat, Morocco A. Tafaj Tirana, Albania
Division of Rheumatology – DiMI
I. Holc Maribor, Slovenia M. Tishler Zrifin, Israel
University of Genoa
A. Iagnocco Turin, Italy A. Tzioufas Athens, Greece
A. Sulli
M. Inanc Istanbul, Turkey I. Uthman Beirut, Lebanon
S. Paolino
R. Ionescu Bucharest, Romania D. Wiek Hünxe, Germany
C. Pizzorni
L. Kazkaz Damascus, Syria H. Yazici Istanbul, Turkey
M. Ghio
G.D. Kitas Manchester, UK D. Vassilopoulos Athens, Greece
B. Ruaro
L. Zakraoui Tunis, Tunisia
M. A. Cimmino
6 7MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
PROGRAM OVERVIEW
THURSDAY April 12th, 2018 FRIDAY April 13th, 2018
hrs PLATEA MAESTRALE ROOM LEVANTE-PONENTE ROOM LIBECCIO ROOM hrs PLATEA MAESTRALE ROOM LEVANTE-PONENTE ROOM LIBECCIO ROOM
11.00 Opening Registrations and Exhibition • THIRD SESSION PEDIATRIC SESSION
related Pediatric Rheumatology in the
08.30-09.40 Osteoarthritis and
13.30-14.00 OPENING CEREMONY • ORAL COMMUNICATIONS
its management Mediterranean area
LECTURE: FOURTH SESSION PATIENT SESSION •
The diet in rheumatic related
14.00-14.30 09.40-10.50 Autoinflammatory and Rare Pregnancy in RMDs: what the
autoimmune diseases: ORAL COMMUNICATIONS
a recipe for therapy? Connective Tissue Diseases patients would like to know
FIRST SESSION related 10.50-11.20 Coffee break (Exhibition Area)
14.30-15.40
Early Rheumatoid Arthritis ORAL COMMUNICATIONS Industry - Sponsored Industry - Sponsored
11.20-11.50
LECTURE SATELLITE LECTURE • SATELLITE LECTURE •
Mediterranean Diet in
15.40-16.10 Industry - Sponsored
the 3rd Millennium: 11.50-12.20
Just Prevention or even Therapy? Industry - Sponsored SATELLITE LECTURE •
SATELLITE SYMPOSIUM • Industry - Sponsored
LECTURE 12.20-12.50
16.10-16.40 Epigenetic Effects of the SATELLITE LECTURE •
Mediterranean Diet
12.50-14.00 POSTER TOUR •
16.40 START THE POSTER EXHIBITION •
16.40-17.10 Coffee break (Exhibition Area) 13.00-14.00 Lunch (Poster Area)
SECOND SESSION LECTURE
related
17.10-18.20 Gouty Arthritis 14.00-14.30 Sun, vitamin D and rheumatic
ORAL COMMUNICATIONS
and dismetabolism diseases
LECTURE LECTURE
Metabolic effects of Fostering physical activity
18.20-18.50
Glucocorticoids:
is there a safe dosage? 14.30-15.00 together with correct nutrition: YOUNG PATIENTS AND
a successful approach but rarely RHEUMATOLOGISTS SESSION •
respected in RMDs The impact of nutrition
FIFTH SESSION and lifestyle on RMDS
related
15.00-16.10 From Raynaud’s phenomenon ORAL COMMUNICATIONS
up to systemic sclerosis
LECTURE
16.10-16.40 Balneotherapy and RMDs: when
where and how to choose
MEET THE EXPERT •
16.40-17.10 Coffee break (Exhibition Area)
(Exhibition Area - Booths 5,6)
PATIENT SESSION •
SIXTH SESSION
related Open Questions to the
17.10-18.30 Systemic Lupus Erythematosus
ORAL COMMUNICATIONS Physician Nutritionist
and related syndromes
• NO CME ACTIVITY and to the Dietician
8 9MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
SCIENTIFIC PROGRAM
We invite all Congress participants to attend the seven Lectures which will be held
during Thursday 12 April and Friday 13 April, 2018.
SATURDAY April 14th, 2018 Nine Scientific Sessions and related Oral communications will be held over the three
days. Other interesting Sessions dedicated to Patients will take place between Friday
hrs PLATEA MAESTRALE ROOM LEVANTE-PONENTE ROOM LIBECCIO ROOM and Saturday; a Pediatric Session on Friday, as well the SPECIAL Ultrasound Session
SPECIAL will run in parallel to the other Scientific Sessions on Saturday.
ULTRASOUND SESSION Industry - Sponsored Satellite Lectures and Satellite Symposia will occupy the slots
SEVENTH SESSION
related What about pitfalls and from 11.20 to 12.50 on Friday 13 April, 2018.
08.30-09.40 Spondyloarthritis
ORAL COMMUNICATIONS misinterpretations related Poster Exhibition and Tour are planned before afternoon Coffee break on Thursday 12
and Psoriatic Arthritis
to the nutritional status in April and before lunch on Friday 13 April.
Rheumatic Diseases?
PATIENT SESSION •
EIGHTH SESSION related
09.40-10.50 The cold hand:
Osteoporosis and life style ORAL COMMUNICATIONS
from symptom to diagnosis
10.50-11.20 Coffee break (Exhibition Area)
NINTH SESSION related PATIENT SESSION •
11.20-12.30
Sjögren syndrome today ORAL COMMUNICATIONS Balneotherapy explained
IMPORTANT NOTICE
12.30-12.45 CLOSING REMARKS
for Scientific Sessions
We invite all Congress participants to attend
the nine Scientific Sessions which will be held
during Thursday 12, Friday 13 and Saturday 14
April, 2018 into the “Platea Maestrale” Room.
Each Session will focus on the priority themes
listed below:
• Epidemiology, nutritional aspects and environmental factors
• The early disease: clinical features and diagnostic tools
• Management: from guidelines up to the last treatment issues
• Management: non pharmacological aspects and unmet needs
• NO CME ACTIVITY
10 11MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
THURSDAY April 12th, 2018
13.30-14.00 OC1:2 MULTICENTER CROSS-SECTIONAL STUDY OF PATIENTS
PLATEA MAESTRALE ROOM OPENING CEREMONY WITH RHEUMATOID ARTHRITIS IN GREECE. RESULTS FROM
NO CME ACTIVITY Welcome from Local Academic, A COHORT OF 2,491 PATIENTS
Hospital and Government Authorities K. Thomas (Athens, Greece)
OC1:3 THE ROLE OF DIET ON RHEUMATOID ARTHRITIS: WHAT DO
14.00-14.30 CLINICAL TRIALS TELL US?
PLATEA MAESTRALE ROOM LECTURE S. Petersson (Nicosia, Cyprus)
The diet in rheumatic autoimmune diseases: OC1:4 FACTORS ASSOCIATED WITH PROGRESSION TO
a recipe for therapy? INFLAMMATORY ARTHRITIS IN THE FIRST-DEGREE
Speaker: RELATI VES (FDR) OF INDIGENOUS NORTH AMERICAN (INA)
Y. Shoenfeld (Tel-Aviv, Israel) RA PATIENTS
Chair: H. EL-Gabalawy (Winnipeg, Canada)
M. Cutolo (Genoa, Italy)
OC1:5 SALT CONSUMPTION MAY BE A RISK FACTOR FOR THE
14.30-15.40 DEVELOPMENT OF ARTHRITIS
PLATEA MAESTRALE ROOM FIRST SESSION L. Carmona (Madrid, Spain)
Early Rheumatoid Arthritis OC1:6 DIETETIC THERAPY AND RHEUMATOID ARTHRITIS
Speakers: L. Denisov (Moscow, Russia)
14.30 Epidemiology, nutritional aspects and environmental factors
I. McInnes (Glasgow,UK) Chair - INTRODUCTION:
14.45 The early disease: clinical features and diagnostic tools R. Caporali (Pavia, Italy)
G. Burmester (Berlin, Germany)
15.40-16.10
15.00 Management: from guidelines up to the last treatment issues
PLATEA MAESTRALE ROOM LECTURE
B. Combe (Montpellier, France)
Mediterranean Diet in the 3rd Millennium:
15.15 Management: non pharmacological aspects and unmet needs Just Prevention or even Therapy?
Z. Szekanecz (Debrecen, Hungary) Speaker:
Chairs: A.Trichopoulou (Athens, Greece)
G. Burmester (Berlin, Germany), C. Montecucco (Pavia, Italy) Chair:
S.G. Sukkar (Genoa, Italy)
14.30-15.40
LEVANTE-PONENTE ROOM FIRST SESSION 16.10-16.40
Early Rheumatoid Arthritis PLATEA MAESTRALE ROOM LECTURE
Concomitant Session and related Oral Communications Epigenetic Effects of the Mediterranean Diet
Oral Sessions are 70-minute sessions and have 10-minute Chairman’s Speaker:
introduction and 6 oral presentations of 10 minutes each included
A. Martinez (Pamplona, Spain)
2 minutes for discussion
Chair:
ORAL COMMUNICATIONS S.G. Sukkar (Genoa, Italy)
Speakers:
OC1:1 VACCINATIONS IN INFLAMMATORY ARTHRITIS PATIENTS 16.40-17.10
S. Khan (Dublin, Ireland) POSTER AREA START THE POSTER EXHIBITION
NO CME ACTIVITY
12 13MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
THURSDAY April 12th, 2018
16.40-17.10 OC2:4 ULTRA-LOW DOSE ANTI-INTERLEUKIN1 IN CHRONIC
EXHIBITION AREA Coffee break GOUT: A SAFE AND SUCCESSFUL COMBINATION THERAPY
WITH LOW DOSE COLCHICINE AND URATE LOWERING
17.10-18.20 AGENTS
PLATEA MAESTRALE ROOM SECOND SESSION M. Capassoni (Florence, Italy)
Gouty arthritis and dismetabolism
OC2:5 SEASONAL VARIATION OF JOINT ASPIRATIONS FOR GOUT
Speakers:
AND CPPD IN A COHORT OF ARTROPATHIC PATIENTS WITH
17.10 Nutritional aspects - including weight loss - for gout:
EFFUSION
an update from clinical epidemiology
M.A. Cimmino (Genoa, Italy)
S.M. Nielsen (Copenhagen, Denmark)
17.25 The early disease: clinical features and diagnostic tools OC2:6 GOUT AND METABOLIC SYNDROME
F. Sivera (Alicante, Spain) N. Zehraoui (Algiers, Algeria)
17.40 Management: from guidelines up to the last treatment issues Chair - INTRODUCTION:
P. Richette (Paris, France) S. Grazio (Zagreb, Croatia)
17.55 Management: non pharmacological aspects and unmet needs
L. Punzi (Padua, Italy) 18.20-18.50
Chairs: PLATEA MAESTRALE ROOM LECTURE
L. Punzi (Padua, Italy), P. Richette (Paris, France) Metabolic effects of Glucocorticoids:
is there a safe dosage?
17.10-18.20 Speaker:
LEVANTE-PONENTE ROOM SECOND SESSION J.W.J. Bijlsma (Utrecht, The Netherlands)
Gouty arthritis and dismetabolism Chair:
Concomitant Session and related Oral Communications M. Cutolo (Genoa, Italy)
Oral Sessions are 70-minute sessions and have 10-minute Chairman’s
introduction and 6 oral presentations of 10 minutes each included
2 minutes for discussion
ORAL COMMUNICATIONS
Speakers:
OC2:1 EFFECT OF POLYDATIN AND RESVERATROL ON CRYSTAL
INDUCED INFLAMMATION: BENEFICIAL IMPLICATIONS
FOR GOUT AND OTHER CRYSTAL-RELATED ARTHROPATHIES
F. Oliviero (Padua, Italy)
OC2:2 ANALYSIS OF THE EFFICACY OF LOW PURINE DIET
IN GOUT PATIENTS
M.S. Eliseev (Moscow, Russia)
OC2:3 COMBINATION OF LOSARTAN AND ALLOPURINOL IN
HYPERTENSIVE PATIENTS WITH HYPERURICEMIA
M. Jordhani (Tirana, Albania)
14 15MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
FRIDAY April 13th, 2018
08.30-09.40 OC3:5 PATIENTS PERCEPTION OF PAIN IN OSTEOARTHRITIS:
PLATEA MAESTRALE ROOM THIRD SESSION RESULTS OF A ROUMANIAN SURVEY
Osteoarthritis and its management I. Saulescu (Bucharest, Romania)
Speakers: OC3:6 KNEE EXTENSOR MUSCLE WEAKNESS AND RADIOGRAPHIC
08.30 Epidemiology, nutritional aspects and environmental factors KNEE OSTEOARTHRITIS PROGRESSION
C. Scire (Ferrara, Italy) A. Dell’Isola (Glasgow, UK - Savona, Italy)
08.45 The early disease: new aspects on the role of imaging Chair - INTRODUCTION:
A. Iagnocco (Turin, Italy) G. Sebastiani (Rome, Italy)
09.00 Management: from guidelines up to the last treatment issues
J.Y. Reginster (Liège, Belgium) 08.30-09.40
09.15 Management: non pharmacological aspects and unmet needs LIBECCIO ROOM Pediatric Rheumatology in the Mediterranean area
P. Sarzi-Puttini (Milan, Italy) Concomitant Session
Speakers:
Chairs:
08.30 Multinational Study on epidemiology, treatment and outcome
A. Iagnocco (Turin, Italy), J.Y. Reginster (Liège, Belgium)
of children with idiopathic juvenile arthritis
A. Ravelli (Genoa, Italy)
08.30-09.40
LEVANTE-PONENTE ROOM THIRD SESSION 09.00 Longitudinal evaluation of growth and puberty development
Osteoarthritis and its management in pediatric rheumatic diseases
N. Ruperto (Genoa, Italy)
Concomitant Session and related Oral Communications
Oral Sessions are 70-minute sessions and have 10-minute Chairman’s 09.30 Discussion
introduction and 6 oral presentations of 10 minutes each included Chairs:
2 minutes for discussion A. Martini (Genoa, Italy), A. Ravelli (Genoa, Italy)
ORAL COMMUNICATIONS
Speakers: 09.40-10.50
OC3:1 MUTUAL INTERACTION BETWEEN OXIDATIVE STRESS PLATEA MAESTRALE ROOM FOURTH SESSION
AND MICRORNAS. AN IN VITRO STUDY ON HUMAN Autoinflammatory and Rare Connective Tissue Diseases
OSTEOARTHRITIC CHONDROCYTE CULTURES Speakers:
S. Cheleschi (Siena, Italy) 09.40 Autoinflammatory diseases: diagnostic criteria,
guidelines and advances
OC3:2 KNEE ARTHRITIS AND METABOLIC SYNDROM
M. Gattorno (Genoa, Italy)
D. Dusa (Constanta, Romania)
09.55 Focus on familial Mediterranean fever
OC3:3 VISCOSUPPLEMENTATION IN NON-SEVERE KNEE H. Lachmann (London, UK)
OSTEOARTHRITIS: A NETWORK META-ANALYSIS OF HIGH
QUALITY RANDOMIZED CLINICAL TRIALS 10.10 Beyond for the vasculitis risk in the Mediterranean
L. Carmona (Madrid, Spain) A. Gul (Istanbul, Turkey)
10.25 Focus on Behçet disease
OC3:4 MUD-BATH THERAPY REGULATES THE EXPRESSION
P. Leccese (Potenza, Italy)
LEVELS OF MICRORNAS IN OSTEOARTHRITIS. EPIGENETIC
CONTRIBUTION TO EXPLAIN THE MECHANISM OF ACTION OF 10.40 NEWS - Short report on a new European Project- ERN,
BALNEOTHERAPY on Rare Connective Tissue Diseases - ReCONNET
S. Cheleschi (Siena, Italy) M. Mosca (Pisa, Italy)
Chairs:
M. Gattorno (Genoa, Italy), H. Lachmann (London, UK)
16 17MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
FRIDAY April 13th, 2018
09.40-10.50 09.40-10.50
LEVANTE-PONENTE ROOM FOURTH SESSION LIBECCIO ROOM PATIENT SESSION
Autoinflammatory and Rare Connective Tissue Diseases NO CME ACTIVITY Pregnancy in RMDs: what the patients would like to know
Concomitant Session and related Oral Communications SESSIONE DEDICATA AI PAZIENTI
Oral Sessions are 70-minute sessions and have 10-minute Chairman’s Gravidanza e malattie reumatiche:
introduction and 6 oral presentations of 10 minutes each included quello che il malato vorrebbe sapere
2 minutes for discussion
Concomitant Session - Sessione Parallela
ORAL COMMUNICATIONS:
Speakers:
Speakers:
LECTURE: Pregnancy yes in RMDs
OC4:1 A GENETIC COHORT STUDY TO GENOTYPE SEVERAL A. Tincani (Brescia, Italy)
INTERLEUKIN GENE POLYMORPHISMS IN A GROUP
OF BEHÇET’S SYNDROME PATIENTS LIVING IN THE LECTURE: Pregnancy No in RMDs
MEDITERRANEAN AREA L. Andreoli (Brescia, Italy)
M.C. Padula (Potenza, Italy) Chair:
A. Tincani (Brescia, Italy)
OC4:2 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED
VASCULITIS IN
M.L. Popescu (Bucharest, Romania)
10.50- 11.20
OC4:3 CAN AUTOANTIBODIES PREDICT OUTCOMES OR SURVIVAL EXHIBITION AREA Coffee break
IN INTERSTITIAL LUNG DISEASE?: RESULTS FROM A
RETROSPECTIVE COHORT STUDY IN GREECE
A. Venetsanopoulou (Athens, Greece) 11.20-11.50
OC4:4 BIRMINGHAM VASCULITIS ACTIVITY INDEX (BVAS) PLATEA MAESTRALE ROOM Concomitants Industry
A USEFUL TOOL IN DISEASE ACTIVITY IN BEHÇET’S DISEASE LEVANTE-PONENTE ROOM Sponsored SATELLITE LECTURES
C. Buzatu (Bucharest, Romania) NO CME ACTIVITY see pag. 66-67
OC4:5 A SEASONAL ONSET FOR POLYMYALGIA RHEUMATICA?
E. Hysa (Genoa, Italy)
OC4:6 ASSESMENT OF ORGAN DAMAGE ACCORDING TO IMACS 11.50-12.50
(INTERNATIONAL MYOSITIS ASSESMENT AND CLINICAL PLATEA MAESTRALE ROOM Concomitants Industry
STUDIES) MYOSITIS DAMAGE INDEX IN 92 PATIENTS WITH
LEVANTE-PONENTE ROOM Sponsored SATELLITE SYMPOSIA/LECTURES
IDIOPATHIC INFLAMMATORY MYOSITIS
NO CME ACTIVITY see pag. 66-67
M. Inanc (Istanbul, Turkey)
Chair - INTRODUCTION:
M. Inanc (Istanbul, Turkey) 12.50-14.00
LUNCH AND POSTER AREA POSTER TOUR
NO CME ACTIVITY see pag. 30-50
13.00-14.00
LUNCH AND POSTER AREA Lunch
18 19MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
FRIDAY April 13th, 2018
14.00-14.30 14.30-15.00
PLATEA MAESTRALE ROOM LECTURE PLATEA MAESTRALE ROOM LECTURE
Sun, vitamin D and rheumatic diseases Fostering physical activity together with correct nutrition:
Speaker: a successful approach but rarely respected in RMDs
M. Cutolo (Genoa, Italy) Speaker:
Chair: G.D. Kitas (Manchester, UK)
G. Minisola (Rome, Italy) Chair:
S. Bombardieri (Pisa, Italy)
14.00-16.40
LIBECCIO ROOM YOUNG PATIENTS AND RHEUMATOLOGISTS SESSION 15.00-16.10
NO CME ACTIVITY The impact of nutrition and lifestyle on RMDS PLATEA MAESTRALE ROOM FIFTH SESSION
Concomitant Session From Raynaud’s phenomenon up to Systemic Sclerosis
Speakers:
Speakers:
14.00 People’s perceptions on nutritional aspects and rheumatic 15.00 Epidemiology, nutritional aspects and environmental factors
disease: Completion of the “Truth or myth” questionnaire U. Muller-Lardner (Bad Nauheim, Germany)
by the audience 15.15 The early disease: clinical features and diagnostic tools
14.10 Nutrition and rheumatic disease: are we really what we eat? M. Matucci Cerinic (Florence, Italy)
E. Philippou (Nicosia, Cyprus - London, UK) 15.30 Management: from guidelines up to the last treatment issues
14.30 The sun and rheumatic disease: friend or foe? C. Denton (London, UK)
M. Cutolo (Genoa, Italy) 15.45 Management: non pharmacological aspects and unmet needs
14.50 The impact of diet in rheumatic diseases O. Distler (Zurich, Switzerland)
C. Daien (Montpellier, France) Chairs:
15.10 Analysis and sharing of the results of the “Truth or myth” C. Denton (London, UK), V. Smith (Ghent, Belgium)
questionnaire at the end of the Session
15.20
“Your 5-a-daY” VIDEO for a healthy and “joint-friendly” 15.00-16.10
exercise regime that can be undertaken as part of the daily routine LEVANTE-PONENTE ROOM FIFTH SESSION
L. Bacoccoli - Personal trainer Virgin Active Village (Perugia, Italy)
From Raynaud’s phenomenon up to Systemic Sclerosis
15.30 WORKSHOP Concomitant Session and related Oral Communications
Problem based cases and discussion Oral Sessions are 70-minute sessions and have 10-minute Chairman’s
(Participants will be divided in groups) introduction and 6 oral presentations of 10 minutes each included
2 minutes for discussion
M. Kouloumas (Nicosia, Cyprus), D. Wiek (Hünxe, Germany)
ORAL COMMUNICATIONS
Chairs:
Speakers:
A. Alunno (Perugia, Italy), M. Kouloumas (Nicosia, Cyprus),
E. Nikiphorou (London, UK), D. Wiek (Hünxe, Germany)
OC5:1 ASSOCIATION OF INTERLEUKIN-17 AND INTERLEUKIN-23
MRNA AND PROTEIN EXPRESSION PROFILES WITH
CLINICAL PRESENTATION IN PATIENTS WITH SYSTEMIC
SCLEROSIS
A. Zekovic (Belgrade, Serbia)
20 21MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
FRIDAY April 13th, 2018
0C5:2 VITAMIN D DEFICIENCY IN SYSTEMIC SCLEROSIS: 17.10-18.30
CORRELATIONS WITH MULTIPLE CLINICAL PARAMETERS, PLATEA MAESTRALE ROOM SIXTH SESSION
SEASONAL VARIATIONS AND TREATMENT EFFECTIVENESS Systemic Lupus Erythematosus and related syndromes
IN EUROPEAN SSC PATIENTS Speakers:
A.C. Trombetta (Genoa, Italy) 17.10 Epidemiology, nutritional aspects and environmental factors
OC5:3 TYPE I INTERFERON INDUCED GENE EXPRESSION IN THE G. Bertsias (Heraklion, Crete, Greece)
PERIPHERAL BLOOD OF PATIENTS WITH SYSTEMIC SCLEROSIS
17.25 The early disease: clinical features and diagnostic investigations
N. Vlachogiannis (Athens, Greece)
D. Boumpas (Athens, Greece)
OC5:4 CORRELATIONS BETWEEN SKIN BLOOD PERFUSION AND
CHOROIDAL THICKNESS IN SYSTEMIC SCLEROSIS PATIENTS 17.40 Management: from guidelines up to the last treatment issues
BEFORE AND AFTER A SHORT TIME TREATMENT WITH A. Doria (Padua, Italy)
PROSTACYCLIN ANALOGUE 18.00 The antiphospholipid syndrome: news on management
A. Sulli (Genoa, Italy) and unmet needs
OC5:5 RELIABILITY OF SIMPLE CAPILLAROSCOPIC DEFINITIONS TO A. Tincani (Brescia, Italy)
DESCRIBE CAPILLARY MORPHOLOGY IN RHEUMATIC DISEASES Chairs:
A. Vanhaecke (Ghent, Belgium) D. Boumpas (Athens, Greece), M. Mosca (Pisa, Italy)
OC5:6 MACITENTAN CONTRASTS THE ACTIVATION OF PROFIBROTIC
INTRACELLULAR SIGNALING PATHWAYS INDUCED 17.10-18.30
BY ENDOTHELIN-1 IN PRIMARY CULTURES OF SKIN LEVANTE-PONENTE ROOM SIXTH SESSION
FIBROBLASTS ISOLATED FROM HEALTHY SUBJECTS Systemic Lupus Erythematosus and related syndromes
S. Soldano (Genoa, Italy) Concomitant Session and related Oral Communications
Oral Sessions are 70-minute sessions and have 10-minute Chairman’s
Chair - INTRODUCTION: introduction and 6 oral presentations of 10 minutes each included
A. Sulli (Genoa, Italy) 2 minutes for discussion
ORAL COMMUNICATIONS
16.10-16.40 Speakers:
PLATEA MAESTRALE ROOM LECTURE OC6:1 TRANSCRIPTIONAL REGULATION OF BAFF-R, BCMA
Balneotherapy and RMDs: when, where and how to choose AND TACI BY MIR-873 AND MIR-1976 IN JUVENILE SLE
Speaker: N.N. Farag (Cairo, Egypt)
A. Fioravanti (Siena, Italy)
OC6:2 THROMBOSPONDIN-1 IS ELEVATED IN THE PLASMA OF
Chair: PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND IS
T. Bender (Budapest, Hungary) CORRELATED WITH FREE ACTIVE TGF-B1 LEVELS, IL-1B
AND IL-17A
P. Vlachoyiannopoulos (Athens, Greece)
16.40-17.10
OC6:3 HYDROXYCHLOROQUINE DOSING: DOES BY IDEAL BODY
EXHIBITION AREA Coffee break
WEIGHT OR GROSS WEIGHT MAKE A DIFFERENCE?
H.S.E. Fung (Waco, Texas-Usa)
16.40-17.10 MEET THE EXPERT OC6:4 AVEMAR, A NEW BENZOQUINONE CONTAINING NATURAL
GRÜNENTHAL PRODUCT IN SLE PATIENTS TREATMENT
EXHIBITION BOOTH S.G. Sukkar (Genoa, Italy)
EXHIBITION AREA
NO CME ACTIVITY
22 23MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
FRIDAY April 13th, 2018 SATURDAY April 14th, 2018
OC6:5 ANTIPHOSPHOLIPID SYNDROME: REVIEW OF 52 CASES OF A
PORTUGUESE RHEUMATOLOGY DEPARTMENT 08.30-09.40
F. Campos Costa (Coimbra, Portugal) PLATEA MAESTRALE ROOM SEVENTH SESSION
Spondyloarthritis and Psoriatic Arthritis
OC6:6 OUTCOME OF ADULT PATIENTS WITH CHILDHOOD-ONSET Speakers:
SYSTEMIC LUPUS ERYTHEMATOSUS AND JUVENILE 08.30 Epidemiology, nutritional aspects and environmental factors
IDIOPATHIC ARTHRITIS IN A SINGLE COHORT R. Lories (Leuven, Belgium)
S. Al-Mayouf (Riyadh, Saudi Arabia)
08.45 The early disease: clinical features and diagnostic tools
I.E. Van der Horst-Bruinsma (Amsterdam, The Netherlands)
Chair - INTRODUCTION:
09.00 Management: from guidelines up to the last treatment issues
P. Miossec (Lyon, France)
R. Ramonda (Padua, Italy)
17.10-18.30 09.15 Management: non pharmacological aspects and unmet needs
LIBECCIO ROOM PATIENT SESSION F. Ciccia (Palermo, Italy)
NO CME ACTIVITY Open Questions to the Physician Nutritionist Chairs:
and to the Dietician S. D’Angelo (Potenza, Italy), R. Lories (Leuven, Belgium)
SESSIONE DEDICATA AI PAZIENTI
Domande libere al Medico nutrizionista ed alla Dietologa 08.30-09.40
Concomitant Session - Sessione Parallela SEVENTH SESSION
LEVANTE-PONENTE ROOM
Chairs: Spondyloarthritis and Psoriatic Arthritis
R. Gradaschi (Genoa, Italy), S.G. Sukkar (Genoa, Italy) Concomitant Session and related Oral Communications
Oral Sessions are 70-minute sessions and have 10-minute Chairman’s
introduction and 6 oral presentations of 10 minutes each included
2 minutes for discussion
ORAL COMMUNICATIONS
Speakers:
OC7:1 METABOLIC SYNDROME, NON ALCOHOLIC FATTY LIVER
DISEASE AND LIVER STIFFNESS IN PSORIATIC ARTHRITIS
AND PSORIASIS PATIENTS: A CROSS-SECTIONAL STUDY
A. Ortolan (Padua, Italy)
OC7:2 DO NOT DO RECOMMENDATIONS IN THE MANAGEMENT OF
COMORBIDITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS.
GECOAX PROJECT
L. Carmona (Madrid, Spain)
OC7:3 EFFECT OF FOOD INTAKE AND AMBIENT PARTICULATE AIR
POLLUTION ON ANKYLOSING SPONDYLITIS DISEASE ACTIVITY
N. Soleimanifar (Tehran, Iran)
OC7:4 BONE DENSITY IN ALGERIAN PATIENTS WITH
ANKYLOSING SPONDYLITIS
B. Bengana (Algiers, Algeria)
24 25MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
SATURDAY April 14th, 2018
OC7:5 EFFICACY AND SAFETY OF USING ETANERCEPT IN 10.25 Management: non pharmacological aspects and unmet needs
TREATMENT OF SPONDYLOARTHROPATHIES, EXPERIENCE J.A.P. Da Silva (Coimbra, Portugal)
OF MONTENEGRO Chairs:
E. Strujic (Podgorica, Montenegro) M.L. Brandi (Florence, Italy), L. Carmona (Madrid, Spain)
OC7:6 A SUSTAINABLE RELIEF OF CHRONIC LOW BACK PAIN 09.40-10.50
IMMEDIATELY AFTER ONE SESSION OF LOW-LEVEL LASER EIGHTH SESSION
LEVANTE-PONENTE ROOM
ACUPUNCTURE THERAPY Osteoporosis and life style
D. Houssien (Jeddah, Saudi Arabia)
Concomitant Session and related Oral Communications
Chair - INTRODUCTION: Oral Sessions are 70-minute sessions and have 10-minute Chairman’s
R. Gerli (Perugia, Italy) introduction and 6 oral presentations of 10 minutes each included
2 minutes for discussion
08.30-09.40 ORAL COMMUNICATIONS
LIBECCIO ROOM SPECIAL ULTRASOUND SESSION Speakers:
What about pitfalls and misinterpretations related 0C8:1 CHARACTERIZATION OF A NOVEL VITAMIN D RECEPTOR
to the nutritional status in Rheumatic Diseases? (VDR) POLYMORPHISM BY SEQUENCE-BASE TYPING
Concomitant Session M.C. Padula (Potenza, Italy)
Speakers: OC8:2 ANKYLOSING SPONDYLITIS BONE: “STIFF AND BRITTLE AS
08.30 Ultrasound in Rheumatology: what, why, when do we assess A CRISTAL GOBLET”
musculoskeletal tissues and other organs? S. Paolino (Genoa, Italy)
A. Iagnocco (Turin, Italy)
OC8:3 VERTEBRAL BONE MINERAL DENSITY EVALUATION USING
08.50 Tips and tricks for pitfalls and misinterpretations related A QUANTITATIVE ULTRASOUND METHOD (ECHOLIGHT) IN A
to the nutritional status in Rheumatic Diseases GROUP OF PATIENTS WITH RHEUMATOID ARTHRITIS
C. Martinoli (Genoa, Italy) R. Decianu (Bucharest, Romania)
09.20 Clinical cases: Ultrasound examinations in patients with OC8:4 FEMORAL NECK BONE MINERAL DENSITY EVALUATION
nutritional status abnormalities USING A QUANTITATIVE ULTRASOUND METHOD
C. Martinoli (Genoa, Italy), B. Ruaro (Genoa, Italy) (ECHOLIGHT) IN A GROUP OF PATIENTS WITH RHEUMATOID
ARTHRITIS
Chair:
R. Decianu (Bucharest, Romania)
A. Iagnocco (Turin, Italy)
OC8:5 COMPARISON OF THE EFFECT OF DENOSUMAB ON BONE
09.40-10.50 MINERAL DENSITY OF LUMBAR SPINE AND FEMORAL NECK
PLATEA MAESTRALE ROOM EIGHTH SESSION IN POSTEMENOPAUSAL WOMEN WITH OSTEOPOROSIS,
Osteoporosis and life style WHEN ADMINISTERED AS FIRST-LINE THERAPY OR AFTER
Speakers: BISPHOSPHONATE
09.40 Epidemiology, nutritional aspects and environmental factors E. Mole (Kifisia, Greece)
L. Carmona (Madrid, Spain) OC8:6 CASE REPORT - CALCIUM INTAKE IN RHEUMATIC DISEASES:
09.55 The early disease: clinical features and diagnostic tools “EST MODUS IN REBUS”
L. Sinigaglia (Milan, Italy) S. Paolino (Genoa, Italy)
10.10 Management: from guidelines up to the last treatment issues Chair - INTRODUCTION:
M.L. Brandi (Florence, Italy) R. Ionescu (Bucharest, Romania)
26 27MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
SATURDAY April 14th, 2018
09.40-10.50 ORAL COMMUNICATIONS
LIBECCIO ROOM PATIENT SESSION Speakers:
NO CME ACTIVITY The cold hand: from symptom to diagnosis OC9:1 ERDJ5 FUNCTION IS INVOLVED IN INFLAMMATORY
SESSIONE DEDICATA AI PAZIENTI MANIFESTATIONS OF SJÖGREN’S SYNDROME IN THE
La mano fredda: dal sintomo alla diagnosi SALIVARY GLAND
Concomitant Session - Sessione Parallela A. Tzioufas (Athens, Greece)
Speakers:
OC9:2 LOW MIR200B-5P LEVELS IN MINOR SALIVARY GLANDS
The cold hand: the symptom
ASSOCIATE WITH LYMPHOMA DEVELOPMENT IN PATIENTS
F. Ingegnoli (Milan, Italy)
WITH SJÖGREN’S SYNDROME (SS)
The cold hand: the diagnosis A. Tzioufas (Athens, Greece)
V. Smith (Ghent, Belgium)
OC9:3 SCORING SYSTEMS IN ULTRASOUND OF SALIVARY GLANDS
Chairs: IN SJÖGREN SYNDROME A VIEW OVER TIME
V. Smith (Ghent, Belgium), F. Ingegnoli (Milan, Italy) V. Iorgoveanu (Bucharest, Romania)
OC9:4 ULTRASONOGRAPHIC SCORING OF THE MAJOR SALIVARY
GLANDS: IS THERE A RELATIONSHIP WITH DISEASE
10.50-11.20
ACTIVITY AND FUNCTIONAL STATUS OF GLANDS
EXHIBITION AREA Coffee break Y. Şahinkaya (Istanbul, Turkey)
OC9:5 SJÖGREN SYNDROME: EVALUATION OF THE DISEASE
11.20-12.30 ACTIVITY USING THE ESSDAI IN 70 PATIENTS
PLATEA MAESTRALE ROOM NINTH SESSION J. Dinis De Freitas (Coimbra, Portugal)
Sjögren syndrome today OC9:6 CLINICAL, BIOLOGICAL AND IMMUNOLOGICAL FEATURES
Speakers: OF SJÖGREN SYNDROME: A RETROSPECTIVE
11.20 New nutritional aspects as possible risk factors: the role of salt MONOCENTRIC TUNISIAN COHORT
S. Colafrancesco (Rome, Italy), G. Valesini (Rome, Italy) M. Kechida (Monastir, Tunisia)
11.35 The early disease: clinical features and diagnostic tools
A. Tzioufas (Athens, Greece) Chair - INTRODUCTION:
N. Damjanov (Belgrade, Serbia)
11.50 Management: from guidelines up to the last treatment issues
X. Mariette (Paris, France)
11.20-12.30
12.10 Management: non pharmacological aspects and unmet needs LIBECCIO ROOM PATIENT SESSION
L. Quartuccio (Udine, Italy) NO CME ACTIVITY Balneotherapy explained
Chairs: SESSIONE DEDICATA AI PAZIENTI
X. Mariette (Paris, France), A. Tzioufas (Athens, Greece) La balneoterapia spiegata: Come usarla?
Concomitant Session
11.20-12.30
Speakers:
LEVANTE-PONENTE ROOM NINTH SESSION
T. Bender (Budapest, Hungary)
Sjögren syndrome today A. Fioravanti (Siena, Italy)
Concomitant Session and related Oral Communications
Chairs:
Oral Sessions are 70-minute sessions and have 10-minute Chairman’s
introduction and 6 oral presentations of 10 minutes each included L. Di Matteo (Pescara, Italy), Z. Szekanecz (Debrecen, Hungary)
2 minutes for discussion
12.30-12.45
PLATEA MAESTRALE ROOM CLOSING REMARKS
28 29MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
POSTER TOUR POSTER TOUR
12.50-14.00
POSTER TOUR POSTER TOUR 1
AUTOINFLAMMATORY AND RARE CONNECTIVE TISSUE DISEASES
FRIDAY April 13th, 2018 Chair: P. Leccese (Potenza, Italy)
SUMMARY
12.50-14.00
POSTER AREA POSTER TOUR 1 PT1:001
IDIOPATHIC INFLAMMATORY MYOPATHIES: CLINICAL CHARACTERISTICS, SURVIVAL AND POOR
NO CME ACTIVITY Autoinflammatory and Rare Connective Tissue Diseases PROGNOSTIC FACTORS OF 110 PATIENTS FROM TURKEY
(Posters from n. 001 to 015) E. Oguz, M. Erdugan, B. Artim Esen, A. Gul, L. Ocal, M. Inanc (Istanbul, Turkey)
POSTER TOUR 2 PT1:002
Gout and arthritis in dismetabolic conditions PARADOXICAL MONOARTHRITIS IN THE CASE RECEIVING ADALIMUMAB TREATMENT DUE TO
(Posters from n. 016 to 018) HIDRADENITIS SUPPURATIVE
S.E. Esmen, S. Arslan, I. Guney (Konya, Turkey)
POSTER TOUR 3
PT1:003
Osteoarthritis: Thermal and pharmacological management DERMATOMYOSITIS ASSOCIATED WITH PAPILLARY THYROID CANCER: A CASE REPORT AND
(Posters from n. 019 to 027) REVIEW OF LITERATURE
S. Ugurlu, U. Yilmaz, H. Ozdogan (Istanbul, Turkey)
POSTER TOUR 4
Osteoporosis/Osteomalacia and malabsorption PT1:004
(Posters from n. 028 to 034) SARCOIDOSIS FOLLOWING MYCOPLASMA PNEUMONIAE INFECTION
I. Sofianos, G. Spiliotis, P. Tzanis, I. Miriokefalitakis (Voula, Greece)
POSTER TOUR 5 PT1:005
Psoriatic arthritis / spondyloarthritis A DIAGNOSTIC AND THERAPEUTIC CHALLENGE - BEHCET’S DISEASE
(Posters from n. 035 to 052) A. Savulescu, L. Ciobica, A. Dumitru, I. Sirbu, L. Panturu, D. Anghel (Bucharest, Romania)
POSTER TOUR 6A-B-C PT1:006
Rheumatoid arthritis ARTHRITIS – THE SUBSTRATE OF A RARE DERMATOLOGIC DISEASE
(Posters from n. 053 to 069, from 070 to 086 and from 087 to 103) C. Radu, L. Groseanu (Bucharest, Romania)
PT1:007
POSTER TOUR 7 SERUM VISFATIN LEVELS IN BEHCET’S DISEASE PATIENTS
Sjögren Syndrome and endocrine rheumatic disorders Z. Ozbalkan-Aslar, M. Enecik, G. Keskin, Y. Araaslan (Ankara, Turkey)
(Posters from n. 104 to 109)
PT1:008
POSTER TOUR 8A-B LYMPHOMA CASE IMITATING TAKAYASU ARTERITIS
Systemic lupus erythematosus / Antiphospholipid syndrome G. Kimyon, R. Erdem, E. Micoogullari, R. Mercan (Hatay, Turkey)
(Posters from n. 110 to 121 and from 122 to 133)
PT1:009
TAKAYASU’S ARTERITIS: EXPERIENCE OF A SINGLE TERTIARY CENTER
POSTER TOUR 9A-B A.B. Kelesoglu Dincer, M. Torgutalp, E.G. Aydemir Guloksuz, E. Uslu Yurteri, M.E. Yayla, I.E. Okatan,
Systemic Sclerosis and Raynaud phenomenon S. Sezer, T.M. Turgay, A. Ates, G. Kinikli (Ankara, Turkey)
(Posters from n. 134 to 146 and from 147 to 159)
30 31MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
POSTER TOUR POSTER TOUR
PT1:010 PT2:018
A GOOD MIMIC: PMR - IS PMR THE ACCURATE DIAGNOSIS?: A SINGLE- CENTER STUDY PULMONARY ADENOCARCINOMA PRESENTED WITH ARTHRITIS
T. Aydin, B.D. Isikoglu, O. Koc, A.B. Kelesoglu Dincer, M. Torgutalp, M.E. Yayla , E. Uslu Urteri, S.E. Esmen, H. Erdogan, E. Kurtipek (Konya, Turkey)
I.E. Okatan, E.G. Aydemir Guloksuz, S. Sezer, T.M. Turgay, A. Ates, G. Kinikli (Ankara, Turkey)
PT1:011
SYSTEMIC SARCOIDOSIS ASSOCIATED WITH VIRAL HEPATITIS C: FORTUITOUS POSTER TOUR 3
ASSOCIATION OR A CAUSAL EFFECT ? Osteoarthritis: Thermal and pharmacological management
M. Kechida, R. Mesfar, W.B. Mansour, M. Hafsa, S. Hammami, I. Khochtali (Monastir, Tunisia) Chair: T. Bender (Budapest, Hungary)
PT1:012
TOCILIZUMAB AS POTENTIAL FIRST OPTION BIOLOGIC THERAPY IN SNITZLER’S SYNDROME PT3:019
E.S. Daia-Iliescu, C. Buzatu, R. Ionescu (Bucharest, Romania) PATIENT’S EXPERIENCE OF ALTERED BODY PERCEPTION IN MUSCULOSKELETAL AND
RHEUMATIC CONDITIONS
PT1:013 A. Viceconti, D. Luzzi, E. Camerone, M. Testa (Savona, Italy)
THE IMPACT OF PROLONGED CORTICOTHERAPY ON DAMAGE PROGRESSION IN PATIENTS WITH
BEHÇET’S DISEASE PT3:020
E.S. Daia-Iliescu, C.G. Buzatu, I. Saulescu, A. Borangiu, L. Groseanu, V. Bojinca, F. Berghea, A LOW FERMENTABLE OLIGO-DI-MONOSACCHARIDES AND POLYOLS DIET IMPROVES
D. Predeteanu, R. Ionescu, D. Opris-Belinski (Bucharest, Romania) SYMPTOMS WITHOUT AFFECTING BODY COMPOSITION AND EXTRACELLULAR BODY WATER IN
FIBROMYALGIC PATIENTS WITH IRRITABLE BOWEL SYNDROME
PT1:014 A. Rossi, M. Bellini, A. Ricciardi, S. Marchi, S. Talarico, M. Mosca, L. Bazzichi (Pisa, Italy)
TERTIARY SYPHILISIS IN A PATIENT WITH TRAPS UNDER CANAKINUMAB TREATMENT:
CASE REPORT PT3:021
D. Temiz Karadag, A. Yazici, A. Cefle (Kocaeli, Turkey) CONTROL AND MANIPULATION OF CONTEXTUAL FACTORS IN MUSCULOSKELETAL PAIN
MANAGEMENT. A VALID OPPORTUNITY TO ENHANCE THE EFFECTIVENESS OF THE SPECIFIC
PT1:015 THERAPY
ADULT STILL’S DISEASE – SERIES OF CLINICAL CASES IN A ROMANIAN REFERENCE CENTER G. Rossettini (1), E. Carlino (2), A. Palese (3), M. Testa (1)
A.M.C. Buta, G. Iftimie, D. Predeteanu, A. Balanescu, C.L. Constantinescu, A. Borangiu, L. Groseanu, (1)
Genoa (Italy), (2) Turin (Italy), (3) Udine (Italy)
I. Saulescu, V.C. Bojinca, D. Mazilu, S. Daia-Iliescu, R. Ionescu, D. Opris-Belinski (Bucharest, Romania)
PT3:022
EFFICACY AND SAFETY OF INTRA-ARTICULAR CORTICOSTEROID ULTRASOUND-GUIDED
INJECTION IN EROSIVE HAND OSTEOARTHRITIS
POSTER TOUR 2 M. Favero, A. Hoxha, P. Frallonardo, E. Belluzzi, M. Lorenzin, A. Ortolan, M. Felicetti, F. Oliviero,
GOUT AND ARTHRITIS IN DISMETABOLIC CONDITIONS L. Punzi, R. Ramonda (Padua,Italy)
Chair: L. Punzi (Padua, Italy)
PT3:023
COULD HYBRID HYALURONIC ACID REPRESENT A VALID APPROACH TO TREAT RIZOARTHROSIS?
PT2:016 A RETROSPECTIVE COMPARATIVE STUDY
MUSCULOSKELETAL ULTRASOUND ABNORMALITIES IN PATIENTS ON DIALYSIS S. Tenti, S. Cheleschi, S. Giannotti, M. Galeazzi, N.A. Giordano, A. Fioravanti (Siena, Italy)
R. Decianu, M. Bojinca, C. Capusa, A. Zugravu, V.C. Bojinca (Bucharest, Romania)
PT3:024
PT2:017 PAIN IN KNEE: MORE THAN JUST WEAR AND TEAR DUE TO OSTEOARTHRITIS
EFFECT OF LOSARTAN IN LOWERING THE LEVEL OF URIC ACID IN PLASMA IN ALBANIAN M. Parvu, G. Novac, A. Nistor, I. Scheip, S. Voidazan (Tg Mures, Romania)
PATIENTS WITH HYPERURICEMIA AND HYPERTENSION
M. Jordhani, D. Ruci, V. Duraj (Tirana, Albania) PT3:025
INTRA-ARTICULAR HYALURONIC ACID FOR KNEE OSTEOARTHRITIS: TWO YEARS EFFICACY OF A
QUARTERLY REGIMEN
F. Galluccio, M. Capassoni, M. Matucci Cerinic (Florence, Italy)
32 33MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
POSTER TOUR POSTER TOUR
PT3:026 PT4:033
THE EFFECTIVENESS OF SAFFRON PILL IN TREATMENT OF OSTEOARTHRITIST: THE 3-YEAR EFFICACY OF ZOLEDRONIC ACID ON BONE MINERAL DENSITY OF LUMBAR SPINE
A RANDOMIZED, DOUBLE-BLIND CONTROLLED TRIAL AND FEMORAL NECK IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
M. Firoozabadi (1), M. Aghei (1), S.Z. Mirfeizi (2), G.R. Roshandel (3), N. AbdolAhi (1) E. Mole, K. Zoupidou, A. Alexoudis, D. Moshou, G. Prelorentzos, S. Gazi (Kifisia, Greece)
(1)
Golestan (Iran), (2) Razavi Khorasan (Iran), (3) Gorgan (Iran)
PT4:034
PT3:027 TENDENCIES OF BONE MINERAL DENSITY IN YOUNG ADULTS AND THE INFLUENCE OF DIET
BALNEOTHERAPY IN KNEE OSTEOARTHRITIS: A COST/EFFECTIVENESS ANALYSIS ALONGSIDE AND OTHER LIFESTYLE HABITS
AN ITALIAN RANDOMIZED CONTROLLED CLINICAL TRIAL I. Badea (Bucharest, Romania)
A. Fioravanti (1), O. Ciani (2), S. Tenti (1), C. Giannitti (1), M. Meregaglia (2), M. Galeazzi (1)
(1)
Siena (Italy), (2) Milan (Italy)
POSTER TOUR 5
PSORIATIC ARTHRITIS / SPONDYLOARTHRITIS
POSTER TOUR 4 Chair: R. Ramonda (Padua, Italy)
OSTEOPOROSIS/OSTEOMALACIA AND MALABSORPTION
Chair: S. Sokolovic (Sarajevo, Bosnia and Herzegovina)
PT5:035
THE PREVALENCE AND COMORBIDITIES ASSOCIATED WITH PSORIATIC ARTHRITIS IN PATIENTS
WITH PSORIASIS: AN OBSERVATIONAL COHORT STUDY
PT4:028
A. Abdalla (1), M. Abd El Haleem (2)
VITAMIN D DEFICIENCY IN THE ACUTE CARE UNIT. IS IT RELATED TO SURVIVAL? (1)
Aswan (Egypt), (2) Benha (Egypt)
I. Kostoglou-Athanassiou (1), E. Pantazi (1), I. Mavropoulos (1), O. Skioti (1), D.Kousouris (1),
S. Kontogiannis (1), P. Athanassiou (2)
(1)
Athens (Greece), (2) Thessaloniki (Greece)
PT5:036
ASSOCIATION BETWEEN LIVER STEATOSIS, METABOLIC PROFILE AND RHEUMATOLOGIC
DISEASES: A SINGLE CENTER STUDY
PT4:029
C. Bruno, R. Grembiale, L. Abenavoli, S. Naty (Catanzaro, Italy)
VITAMIN D DEFICIENCY AND OSTEOMALACIA IN ACUTELY ILL PATIENTS AFTER SURGICAL
TREATMENT FOR COLON CANCER
P. Athanassiou (1), L. Athanassiou (2), P. Potamousi (2), R. Alevizou (2), M. Digalakis (2),
PT5:037
OBESITY AND RESPONSE TO TNF INHIBITORS IN PATIENTS WITH ANKYLOSING SPONDYLITIS –
I. Kostoglou-Athanassiou (2)
DATA FROM A ROMANIAN COHORT
(1)
Thessaloniki (Greece), (2) Athens (Greece)
C. Ancuta, C. Pomirleanu, R. Paiu, E. Ancuta, C. Iordache, I. Esanu, R. Chirieac (Iasi, Romania)
PT4:030
EFFECTIVNESS OF DENOSUMAB IN ADJUSTMENT OF OSTEOPOROSIS TREATMENT IN PATIENTS
PT5:038
PREVALENCE OF COMORBIDITIES IN PSORIATIC ARTHRITIS: A CROSS-SECTIONAL STUDY
WITH RHEUMATOID ARTHRITIS
T.E. Gudu, A. Peltea, M. Abobului, A. Balanescu, F. Berghea, V. Bojinca, A. Borangiu,
R. Yatsyshyn, O. Shtefiuk, I. Popadynets, G. Kuryliv, I. Stoika (Ivano-Frankivsk, Ukraine)
C. Constantinescu, L. Groseanu, M. Negru, D. Opris-Belinski, D. Predeteanu, I. Saulescu, V. Vlad,
R. Ionescu (Bucharest, Romania)
PT4:031
EVALUATION OF EFFECTS OF ADAPTED PHYSICAL ACTIVITY PROGRAM ON FUNCTIONAL
ORGANIC INDEXES AND BMD IN OSTEOPOROTIC PATIENTS TREATED WITH DENOSUMAB
PT5:039
HYPERURICEMIA IN PSORIATIC ARTHRITIS: PREVALENCE AND ASSOCIATED FACTORS
A. Romeo, C. Baiano (Syracuse, Italy)
T.E. Gudu, A. Peltea, A. Balanescu, V. Bojinca, D. Opris-Belinski, D. Predeteanu, R. Ionescu
(Bucharest, Romania)
PT4:032
BREAST CANCER AND SKELETAL HEALTH: EVALUATION OF BONE MINERAL DENSITY AND
FRACTURE RISK
PT5:040
METABOLIC SYNDROME AND ANKYLOSING SPONDYLITIS IN ALGERIAN PEOPLE
S. Paolino, E. Gotelli, V. Tomatis, R. Murialdo, L. Tixi, R. Gonella, A. Ballestrero, M. Cutolo (Genoa, Italy)
N.C. Zehraoui, R. Benaziez-Boutalebi, O. Cheikh, M. Berkache, M. A. Ifticene, C. Dahou-Makhloufi
(Algiers, Algeria)
34 35MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
POSTER TOUR POSTER TOUR
PT5:041 PT5:049
PARADOXICAL INFLAMMATORY BOWEL DISEASE IN PATIENTS WITH SPONDYLOARTHROPATHIES TWO-YEARS SURVIVAL OF USTEKINUMAB IN PSORIATIC ARTHRITIS PATIENTS
TREATED WITH ANTI-TNF AGENTS R.D. González Benítez, I. Janta, B. Serrano Benavente, J. C. Nieto Gonzalez, M. Correyero,
C. Ancuta, C. Pomirleanu, R. Paiu, E. Ancuta, R. Chirieac (Iasi, Romania) C.M. Gonzalez Fernandez (Madrid, Spain)
PT5:042 PT5:050
ASAS HEALTH INDEX AND ENVIRONMENTAL FACTORS (ASAS HI/EF) IN PATIENTS WITH PROMPT CLINICAL RESPONSE TO SECUKINUMAB IN PATIENTS WITH AXIAL
ANKYLOSING SPONDYLITIS AND CONCOMITANT FIBROMYALGIA SPONDYLOARTHRITIS: REAL-LIFE OBSERVATIONAL DATA FROM THREE ITALIAN REFERRAL
I. Shapoval, M. Stanislavchuk, K. Zaichko (Vinnytsia, Ukraine) CENTERS
S. Gentileschi (1), A. Vitale (1), D. Rigante (2), G. Lopalco (3), G. Emmi (4), I. Orlando (1), G. Di Scala (4),
PT5:043 J. Sota (1), C. Fabiani (5), B. Frediani (1), M. Galeazzi (1), G. Lapadula (3), F. Iannone (3), L. Cantarini (1)
DNA METHYLOME AND SERUM PROTEOME ANALYSES IDENTIFY NEW BIOMARKERS OF (1)
Siena (Italy) (2) Rome (Italy) (3) Bari (Italy) (4) Florence (Italy) (5) Milan (Italy)
PSORIASIS AND PSORIATIC ARTHRITIS IN MONOZYGOTIC TWINS
M. Meroni (1), A. Ceribelli (1), E.M. Paraboschi (1), N. Isailovic (1), E. Generali (1), M. Robusto (1), PT5:051
M. De Santis (1), G. Cardamone (1), F. Sacrini (1), A. Costanzo (1), S. Duga (1), C. Selmi (2) THE ASSESSMENT OF THE RELATION BETWEEN SERUM URIC ACID LEVEL AND DISEASE
(1)
Rozzano, MI (Italy), (2) Milan (Italy) ACTIVITY IN ANKYLOSING SPONDYLYTIS
I.H. Dursun, F. Cosan, B. Yilmazer, A. Cefle (Kocaeli, Turkey)
PT5:044
PROTEIN LEVELS AND AUTOANTIBODIES AGAINST LL37 AND IFI16 NUCLEIC ACID SENSORS IN PT5:052
PSORIATIC ARTHRITIS OBESITY INTERACTS WITH RESPONSE AND INCREASES THE RISK OF HYPERTRANSAMINEMINA
M. Meroni (1), N. Isailovic (1), M. De Santis (1), A. Ceribelli (1), E. Generali (1), L. Altamore (2), G. Sabatino(2), IN PSORIATIC ARTHRITIS
P. Rovero (2), A.M. Papini (2), V. Caneparo (3), S. Landolfo (3), M. Gariglio (4), M. De Andrea (3), C. Selmi (1,5) L. Carmona (1), E. Galíndez (2)
(1)
Rozzano, MI (Italy), (2) Florence (Italy), (3) Turin (Italy), (4) Novara (Italy), (5) Milan (Italy)
(1)
Madrid (Spain) (2) Bilbao (Spain)
PT5:045
THE INFLUENCE OF SMOKING ON RESPONSE TO ANTI TNF THERAPY IN PATIENTS WITH
ANKYLOSING SPONDYLITIS POSTER TOUR 6A
D. Anghel, C. Jurcut, A. Anghel, M.M Negru, A.E. Savulescu, L. Panturu (Bucharest, Romania) RHEUMATOID ARTHRITIS
Chair: A. Alunno (Perugia, Italy)
PT5:046
FACTORS ASSOCIATED WITH STOPPING BIOLOGICAL TREATMENT IN PATIENTS WITH
ANKYLOSING SPONDYLITIS PT6A:053
G. Iftimie, C. Buta, L. Groseanu, R. Ionescu, D. Opris-Belinski (Bucharest, Romania) RITUXIMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN A PATIENT WITH COMORBIDITY
– CHONDROSARCOMA/OSTEOSARCOMA OF THE CAVERNOUS SINUS
PT5:047 M. Baresic, L. Simetic, D. Herceg, B. Anic (Zagreb, Croatia)
ULTRASONOGRAPHIC CHANGES OF ASYMPTOMATIC ANTERIOR CHEST WALL JOINTS
IN ANKYLOSING SPONDYLITIS AND THEIR RELATION TO CHEST EXPANSION PT6A:054
F. Hassan , M. Mortada, A. Bakry, A. Elsammak (Zagazig, Egypt) PERIPHERAL BLOOD B-CELL SUBSETS IN PATIENTS WITH VERY EARLY AND ESTABLISHED
RHEUMATOID ARTHRITIS
PT5:048 A. Avdeeva, A. Aleksankin, T. Popkova, E. Suponitskaya, E. Nasonov (Moscow, Russia)
GLOBAL HEALTH ASSESSMENT BY RHEUMATOLOGIST AND BY PATIENT IN PSORIATIC
ARTHRITIS, RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS PT6A:055
F. Grubisic, H. Skala Kavangh, I. Doko, S. Grazio (Zagreg, Croatia) IS IT POSSIBLE TO REPLACE THE RADIOLOGICAL ASSESSMENT OF DESTRUCTIVE CHANGES IN
RHEUMATOID ARTHRITIS (RA) BY ULTRASOUND (US) EXAMINATION?
O. Alexeeva, A. Smirnov, A. Volkov, E. Nasonov (Moscow, Russia)
36 37MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
POSTER TOUR POSTER TOUR
PT6A:056 PT6A:066
EDUCATING PEOPLE WITH RMDS TO FOLLOW A CORRECT DIET: AN INNOVATIVE 3 STEPS THE INFLUENCE OF SMOKING ON CLINICAL RESPONSE TO ETANERCEPT THERAPY IN PATIENTS
PROJECT WITH RHEUMATOID ARTHRITIS
U.G. Viora, S. Severoni, S. Tonolo (Rome, Italy) S. Zivojinovic, M. Bukilica, N. Damjanov (Belgrade, Serbia)
PT6A:057 PT6A:067
FOLIC ACID SUPPLEMENTATION REDUCES METHOTREXATE EFFICACY AND DELAY CLINICAL SECONDARY SARCOPENIA IN PATIENTS WITH RHEUMATOID ARTHRITIS
IMPROVEMENT IN RHEUMATOID ARTHRITIS PATIENTS R. Yatsyshyn, I. Stoika (Ivano-Frankivsk, Ukraine)
A. Sulli, S. Paolino, C. Pizzorni, E. Alessandri, M. Patanè, M. Ghio, M. Cutolo (Genoa, Italy)
PT6A:068
PT6A:058 DIET IN CHILDREN WITH IJA: AN INNOVATIVE 4 STEPS PROJECT TO OVERCOME CULTURAL
CLINICAL AND ECONOMIC VALUE OF SERUM AUTOANTIBODIES MULTI-TESTING IN RHEUMATOID BARRIERS
ARTHRITIS IN THE MEDITERRANEAN AREA U.G. Viora, G. Mascarino, S. Tonolo (Rome, Italy)
B. Mascialino (1), S. Swiniarski (2), I. Gehring (2), M. Poorafshar (1)
(1)
Uppsala (Sweden), (2) Freiburg (Germany) PT6A:069
27-YEARS OLD FEMALE WITH POLYARTHRITIS, DRYNESS SYNDROME AND ACUTE LOSS OF
PT6A:059 VISUAL ACUITY
CAN DIET MODIFY RISK AND COURSE OF INFLAMMATION AND MALIGNANCY? P. Tzanis, I. Sofianos, G. Spiliotis, I. Myriokefalitakis (Voula, Greece)
E. Kucharz (Katowice, Poland)
PT6A:060
TRADITIONAL TYPE 2 DIABETES RISK FACTORS AND INSULIN RESISTANCE IN PATIENTS WITH POSTER TOUR 6B
RHEUMATOID ARTHRITIS RHEUMATOID ARTHRITIS
L. Kondrateva, T. Popkova (Moscow, Russia) Chair: M. Cimmino (Genoa, Italy)
PT6A:061
THE EFFECT OF TOCILIZUMAB THERAPY ON THE BODY MASS INDEX, WAIST AND HIP PT6B:070
CIRCUMFERENCE, LIPIDS PROFILES IN PATIENTS WITH RHEUMATOID ARTHRITIS RHEUMATOID ARTHRITIS PATIENT WITH MASS ON THE ANTERIOR CHEST WALL
E. Gerasimova, T. Popkova, A. Martinova, E. Zhilyaev, G. Lukina (Moscow, Russia) Ö. Soysal Gündüz, G. Gunduz, D. Demir (Manisa, Turkey)
PT6A:063 PT6B:071
SMOKING AND RHEUMATOID ARTHRITIS A STRUCTURED PROTOCOL FOR THE EVALUATION OF CARDIO-VASCULAR RISK IN ARTHRITIS
D. Dusa, M. Suta (Constanta, Romania) PATIENTS
F. Sivera, N. Alberola, G. Albert, C. Fernandez-Carballido, R. Martin, T. Pedraz (Elda, Spain)
PT6A:064
A PATIENT PRESENTING WITH JAW PAIN. DIAGNOSIS, TREATMENT AND REVIEW OF THE PT6B:072
LITERATURE EFFECTS OF MEDITERRANEAN DIET AND PHYSICAL THERAPY IN EARLY STAGES OF
C. Christodoulou (Larnaca – Nicosia, Cyprus) OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
L.M. Ailioaie, C. Ailioaie (Iasi, Romania)
PT6A:065
THE INFLUENCE OF ABATACEPT ON BIOMARKERS LEVEL IN PATIENTS WITH RHEUMATOID PT6B:073
ARTHRITIS CONSTRUCT VALIDITY, REPRODUCIBILITY AND FEASIBILITY OF THE PRO-THERMOMETER-
M.B. Borisova, G.V. Lukina, Y.A. Sigidin, E.S. Aronova, E.L. Luchihina, D.E. Karateev, E.N. Alexandrova, 5ITEM (5T-PROS) IN THE EVALUATION OF THE HEALTH STATUS IN PATIENTS WITH RHEUMATOID
A.A. Novikov, M. Cherkasova, S.I. Glukhova, E.L. Nasonov (Moscow, Russia) ARTHRITIS, SPONDYLOARTHRITIS AND FIBROMYAL
F. Salaffi, S. Farah, M. Di Carlo, M. Carotti (Ancona, Italy)
38 39MEDITERRANEAN CONGRESS OF
EFFECTS OF THE DIET AND THE CLIMATE IN RHEUMATIC AND MUSCULOSKELETAL DISEASES
POSTER TOUR POSTER TOUR
PT6B:074 PT6B:084
CONSTRUCT VALIDITY AND INTERPRETABILITY OF THE QUICKDASH IN THE ASSESSMENT OF CONTRIBUTON OF VITAMIN D RECEPTOR FOKI GENE POLYMORPHISM ON DISEASE SEVERITY
RHEUMATOID ARTHRITIS HAND DISABILITY AND LONG TERM DISEASE OUTCOME IN JUVENILE IDIOPATHIC ARTHRITIS (JIA)
F. Salaffi, S. Farah, M. Di Carlo, M. Carotti (Ancona, Italy) D. Lazarevic (1), J. Vojinovic (1), G. Susic (2), J. Basic (1), J. Milenkovic (1)
(1)
Niš (Serbia), (2) Belgrade (Serbia)
PT6B:075
EVOLUTION OF PAIN IN RHEUMATOID ARTHRITIS TREATED WITH ANTI-INTERLEUKIN 6 PT6B:085
N. Blidi, N. Saidi, R. Benaziez, N. Zehraoui, M.A. Ifticene, F. Mechid, C. Dahou-Makhloufi IS PROTEIN C REACTIVE RELATED TO METABOLIC SYNDROME IN RHUMATOID ARTHRITIS?
(Algiers, Algeria) M. Kechida (1), N. Lorenzo Vilalba (2), R. Mesfar (1), Y. Alvarado Funes (2), R. Klii (1), S. Hammami (1),
I. Khochtali (1)
PT6B:076 (1)
Monastir (Tunisia), (2)
Liège (Belgium)
PATIENTS’ SATISFACTION WITH HEALTH CARE PROVIDED IN AN OUTPATIENT CLINIC FOR
RHEUMATOLOGY: RESULTS OF A QUESTIONNAIRE STUDY OF SPECIFIC ASPECTS OF CARE PT6B:086
D. Cubelic (1), M. Reihl (2), M. Mayer (1), B. Anic (1) THE EFFICACY AND SAFETY OF METHOTREXATE IN A DOSE 25 MG PER WEEK AND MORE IN
(1)
Zagreb (Croatia), (2) Vukovar (Croatia) PATIENTS WITH RHEUMATOID ARTHRITIS.
G. Gridneva, Y. Muraviev (Moscow, Russia)
PT6B:077
PREDICTIVE FACTORS OF EVOLUTION OF EARLY INFLAMMATORY ARTHRITIS TO RHEUMATOID
ARTHRITIS
F. Rahal, R. Chetouane, S. Haid, N. Brahimi, A. Ladjouze-Rezig, F. Hanni (Algiers, Algeria) POSTER TOUR 6C
RHEUMATOID ARTHRITIS
PT6B:078 Chair: A. Iagnocco (Turin, Italy)
ULTRASONOGRAPHYC FINDINGS OF HIP JOINTS IN PATIENTS WITH RHEUMATOID ARTRITIS
S. Prodanovic, G. Radunovic, N. Damjanov (Belgrade, Serbia)
PT6C:087
PT6B:080 IMPAIRED WOUND HEALING DUE TO LEFLUNOMIDE USE IN PATIENTS WITH RHEUMATOID
RITUXIMAB: COMPARISON CLINICAL AND ANTI-DESTRUCTIVE EFFECTS AND B-CELL COUNT IN ARTHRITIS
RHEUMATOID ARTHRITIS PATIENTS. V. Gerdan (Izmir, Turkey)
A. Pivanova, G. Lukina, Y. Sigidin, A. Smirnov, S. Glukhova, A. Kuznetsova, K. Kuzikyants, E. Nasonov
(Moscow, Russia) PT6C:088
THE EFFECT OF GENDER ON ANEMIA FREQUENCY IN RHEUMATOID ARTHRITIS
PT6B:081 S.E. Esmen, A. Tekinalp (Konya, Turkey)
EFFECT OF A DYNAMIC EXERCISE PROGRAM IN COMBINATION WITH A MEDITERRANEAN DIET IN
WEIGHT AND HANDGRIP STRENGTH IN WOMEN WITH RHEUMATOID ARTHRITIS PT6C:089
M. Ogata Medel, M. Lozada Mellado, J. M. García Morales, A. Hinojosa Azaola, N. Morales Herrero, THE RELATIONSHIP OF ANEMIA FREQUENCY AND DISEASE ACTIVITY IN THE PATIENTS WITH
L. Llorente, J. Alcocer Varela , J. A. Pineda Juárez, Cervantes Gaytán, L. Castillo Martínez RHEUMATOID ARTHRITIS
(Mexico City, Mexico) S.E. Esmen, A. Tekinalp (Konya, Turkey)
PT6B:082 PT6C:090
RHEUMATOID ARTHRITIS: FREQUENCY AND INFLUENCE OF TOBACCO AND BODY MASS INDEX KIR GENE DISTRIBUTION IN TURKISH PATIENTS WITH RHEUMATOID ARTHRITIS
(BMI) IN THE ACTIVITY OF THE DISEASE E. Erken, F. Kocabas, O. Ozturk, S. Dinkci, N. Yilmaz (Adana, Turkey)
E. Mussano, L. Onetti, I. Cadile, M. Werner, M.V. Gazzoni, M.C. Taboada, M.I. Stancich, R. Jurado
(Cordoba, Argentina) PT6C:091
FACTORS CONTRIBUTING TO DISABILITY IN RHEUMATOID ARTHRITIS PATIENTS: AN EGYPTIAN
PT6B:083 MULTICENTER STUDY
PERIODONTITIS IN EARLY RHEUMATOID ARTHRITIS: CASE-CONTROL STUDY M. Eissa (1), M. Hammad (2), G. Dawa (2)
F. Mechid, C. Dahou, M. Meddad, S. Salah, S. Merad (Algiers, Algeria) (1)
Cairo (Egypt), (2) Zagazig (Egypt)
40 41You can also read
